Pharmerica (PMC) Tops Q1 EPS by 2c; Reaffirms
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
PharMerica Reports First Quarter 2017 Results
May 10, 2017 8:00 AM EDTStrong Financial Results
Reaffirms Annual 2017 Guidance
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (the Corporation, PharMerica or the Company) (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and specialty pharmacy services, today reported its financial results for the first quarter ended March 31, 2017.
             1Q17 Results  ÂComparison to 1Q16
 ÂComparison to 4Q16
Revenue   $566.8 million   Increase of 8.1%   Increase of 6.1% Gross profit   $87.9 million   ... More